{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:01:10Z","timestamp":1776733270858,"version":"3.51.2"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.nmd.2023.09.004","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T21:08:48Z","timestamp":1695157728000},"page":"776-781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Systemic under treatment of heart disease in patients with Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"33","author":[{"given":"Peter","family":"Karachunski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0246-9692","authenticated-orcid":false,"given":"DeWayne","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2023.09.004_bib0001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2023.09.004_bib0002","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.004_bib0003","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.004_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1532-429X-15-107","article-title":"Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function","volume":"15","author":"Hor","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.nmd.2023.09.004_bib0005","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1440-1754.2012.02428.x","article-title":"Evaluation of the North Star Ambulatory Assessment scale and cardiac abnormalities in ambulant boys with Duchenne muscular dystrophy","volume":"48","author":"Ergul","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.nmd.2023.09.004_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.114.001338","article-title":"Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in Duchenne muscular dystrophy","volume":"4","author":"Tandon","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nmd.2023.09.004_bib0007","article-title":"A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophy","volume":"5","author":"Allen","year":"2013","journal-title":"PLoS Curr Muscular Dystrophy"},{"key":"10.1016\/j.nmd.2023.09.004_bib0008","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ahj.2007.05.014","article-title":"Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years\u2019 follow-up","volume":"154","author":"Duboc","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.nmd.2023.09.004_bib0009","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1161\/CIRCULATIONAHA.114.015151","article-title":"Contemporary cardiac issues in Duchenne muscular dystrophy","volume":"131","author":"McNally","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.nmd.2023.09.004_bib0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2023.09.004_bib0011","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","article-title":"Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy","volume":"45","author":"Duboc","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nmd.2023.09.004_bib0012","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/eurheartj\/ehab054","article-title":"Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy-analysis of registry data","volume":"42","author":"Porcher","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nmd.2023.09.004_bib0013","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mayocp.2015.10.019","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients without heart failure? Insights from 254,301 patients from randomized trials","volume":"91","author":"Bangalore","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nmd.2023.09.004_bib0014","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41436-018-0086-5","article-title":"MOVR-NeuroMuscular ObserVational Research, a unified data hub for neuromuscular diseases","volume":"21","author":"Howell","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2023.09.004_bib0015","unstructured":"R Core Team. R: a language and environment for statistical computing 2022."},{"key":"10.1016\/j.nmd.2023.09.004_bib0016","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00246-014-0972-9","article-title":"Regional circumferential strain is a biomarker for disease severity in duchenne muscular dystrophy heart disease: a cross-sectional study","volume":"36","author":"Hor","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.nmd.2023.09.004_bib0017","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ppul.25227","article-title":"The role of imaging in characterizing the cardiac natural history of Duchenne muscular dystrophy","volume":"56","author":"Lee","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.nmd.2023.09.004_bib0018","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nmd.2023.09.004_bib0019","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-deficient cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nmd.2023.09.004_bib0020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.braindev.2007.01.009","article-title":"Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients","volume":"29","author":"Matsumura","year":"2007","journal-title":"Brain Dev"},{"key":"10.1016\/j.nmd.2023.09.004_bib0021","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jacc.2008.12.032","article-title":"Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy. A cardiac magnetic resonance tagging study","volume":"53","author":"Hor","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nmd.2023.09.004_bib0022","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.nmd.2018.06.014","article-title":"Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy","volume":"28","author":"Hor","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2023.09.004_bib0023","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrendo.2015.6","article-title":"Novel RAAS agonists and antagonists: clinical applications and controversies","volume":"11","author":"Romero","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.nmd.2023.09.004_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ppedcard.2019.01.001","article-title":"Use of advanced heart failure therapies in Duchenne muscular dystrophy","volume":"53","author":"Wittlieb-Weber","year":"2019","journal-title":"Prog Pediatr Cardiol"},{"key":"10.1016\/j.nmd.2023.09.004_bib0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.healun.2022.09.003","article-title":"Initial multicenter experience with ventricular assist devices in children and young adults with muscular dystrophy: an ACTION registry analysis","volume":"42","author":"Nandi","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.nmd.2023.09.004_bib0026","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yjmcc.2014.08.013","article-title":"Dystrobrevin increases dystrophin's binding to the dystrophin-glycoprotein complex and provides protection during cardiac stress","volume":"76","author":"Strakova","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nmd.2023.09.004_bib0027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2019.01.013","article-title":"Acute AT1R blockade prevents isoproterenol-induced injury in mdx hearts","volume":"128","author":"Meyers","year":"2019","journal-title":"J Mol Cell Cardiol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623007228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623007228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:14:20Z","timestamp":1760775260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623007228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0960896623007228"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.09.004","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic under treatment of heart disease in patients with Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}